课题基金 / 基金详情

WATER SOLUBLE OCTANUCLEAR IRON III CLUSTERS AS MRI CONTRAST AGENTS

WATER SOLUBLE OCTANUCLEAR IRON III CLUSTERS AS MRI CONTRAST AGENTS
水溶性八核铁 III 团簇作为 MRI 造影剂
批准号:
6472799
负责人:
RAPHAEL G RAPTIS
金额:
$11.03万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-07-01 至 2002-06-30

项目摘要

项目成果

RAPHAEL G RAPTIS的其他基金

相似基金

相关文献

中文摘要
翻译
描述(改编自应用):通过制备水溶性配合物,
英文摘要
Description (Adapted from Application): By preparing water-soluble complexes, which differ in shape and size from the currently available gadolinium-based MRI contrast agents--the parent complex is approximately spherical with about a 12A diameter--the investigators wish to satisfy the need for new target-specific contrast agents. They will prepare water-soluble derivatives of an octanuclear Fe(III)-oxo-pyrazolato cluster, Fe8(mu4-O)4(mu-pz)12Cl4 (pz=pyrazolato anion), so that they can be screened as potential contrast enhancing agents for in vivo MRI applications. The parent cluster has a large magnetic moment, chemical stability under a wide range of conditions, and several peripheral sites available for substitution, and thus, manipulation of its size, shape, and solubility. As a reliable synthesis of this hydrophobic cluster is established, they will now prepare its water-soluble derivatives by introducing hydrophilic groups at its periphery by two methods: (1) substitution of the terminal chloride ligands, and (2) substitution at the sterically unhindered 4- position of the pyrazole rings. Once the new octanuclear clusters are fully characterized by standard methods, their relaxivity and biological activity will be determined.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Synthesis and Pre-Clinical Evaluation of Targeted, Iron-Based MRI Contrast Agents
Octanuclear Iron Clusters as MRI Contrast Agents
WATER SOLUBLE OCTANUCLEAR IRON III CLUSTERS AS MRI CONTRAST AGENTS
WATER SOLUBLE OCTANUCLEAR IRON III CLUSTERS AS MRI CONTRAST AGENTS
海外基金